ARCHIVES

Director’s Advisory Committee to Make Advice “Kosher”

This article is from The Cancer Letter archive.

Vol. 23 No. 09 | March 7, 1997

Download PDF Visit The Full Archive

Related Articles

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

Clinton Budget Proposes Increase For AIDS, tuberculosis, In FY94

April 23, 1993

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989